AbbVie must pay $15 million in Depakote birth-defect trial: jury

Reuters, 9 June 2017
Author: Nate Raymond
“A federal jury on Friday awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc’s (ABBV.N) bipolar disorder drug Depakote that she took while pregnant, in the latest trial among hundreds of lawsuits over the product.”
Find article here.